About

Albie Lavin is the inventor of the Impel Pharmaceuticals I143 device, the first nasal spray developed around the use of a single-use compressed gas cylinder.

Mr Lavin has spent the last five years developing novel nasal spray devices designed to achieve precision olfactory delivery, including combination products indicated for acute agitation, Parkinson’s disease and migraine.

He currently serves as a Technical Advisory Consultant to Picocyl and remains passionate about developing novel device solutions for the drug delivery space.

Contributions

PULMONARY

BENEFITS OF INNOVATIVE COMPRESSED GAS-POWERED INTRANASAL DRUG DELIVERY DEVICES

Albie Lavin discusses the exciting potential of propellant-driven systems for intranasal delivery, and how Picocyl’s Pico-Cylinders provide the ideal mechanism to take advantage of this potential.

More contributions

INJECTION

GAS-POWERED AUTOINJECTOR PLATFORM ENABLES BIOLOGICS DRUG DELIVERY

Matt McCawley and Albie Lavin discuss Altaviz's universal biologics autoinjector platform, highlighting how its gas-powered drive system, based on Pico-Cylinders, provides numerous benefits over legacy spring-powered autoinjectors.